Page last updated: 2024-12-11
bleomycin a6
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
bleomycin A6: forms conjugate with monoclonal antibody anti-CCT2 which binds to leukemia cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9877229 |
CHEMBL ID | 1231529 |
MeSH ID | M0149402 |
Synonyms (19)
Synonym |
---|
CHEMBL1231529 |
pingyangmycin a6 |
bleomycinamide, n1-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)- |
boanmycin |
bleomycin a6 |
bleomycinamide, n(sup 1)-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)- |
n(sup 1)-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)bleomycinamide |
zhengguangmycin a6 |
37293-17-7 |
0b19ocb220 , |
unii-0b19ocb220 |
bleomycinamide, n1-(3-((4-((3- aminopropyl)amino)butyl)amino)propyl)- |
bleomycin a6 [who-dd] |
[(2s,3r,4r,5s,6s)-2-[(3r,4r,5r,6r)-2-[(1r,2s)-2-[[6-amino-2-[(1s)-3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[(2s,3r,4r)-5-[[(2r,3s)-1-[2-[4-[4-[3-[4-(3-aminopropylamino)butylamino]propylcarbamoyl]-1,3- |
(2r,3s,4s,5r,6r)-2-{[(2r,3s,4s,5s,6s)-2-{[(1r,2s)-2-[({6-amino-2-[(1s)-3-amino-1-{[(2s)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl]-5-methylpyrimidin-4-yl}carbonyl)amino]-3-{[(1r,2s,3s)-4-{[(1s,2r)-1-{[2-(4-{[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl |
Q27236557 |
DTXSID001318678 |
HY-147359 |
CS-0567262 |
Research Excerpts
Overview
Bleomycin A6 is an antineoplastic antibiotic.
Excerpt | Reference | Relevance |
---|---|---|
"Bleomycin A6 is an antineoplastic antibiotic. " | ( [Preclinical pharmacologic evaluation of bleomycin A6]. Lin, FT, 1989) | 1.99 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" At a tolerable dosage level, bleomycin A6 exerted remarkable growth inhibition on human colon cancer HT-29 and cecum cancer Hce-8693 xenografts (approximately 90% inhibition)." | ( [Inhibitory effect of bleomycin A6 on human colon cancer xenografts in nude mice]. Deng, Y, 1990) | 0.88 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (30)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (20.00) | 18.7374 |
1990's | 13 (43.33) | 18.2507 |
2000's | 4 (13.33) | 29.6817 |
2010's | 6 (20.00) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.25) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (6.67%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 28 (93.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |